Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003463110 | SCV004197777 | likely pathogenic | Mitochondrial complex 1 deficiency, nuclear type 9 | 2023-08-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003699111 | SCV004460518 | pathogenic | not provided | 2023-04-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with NDUFS6-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu81Glyfs*4) in the NDUFS6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NDUFS6 are known to be pathogenic (PMID: 15372108). |